Article(id=1329914748021355266, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.06.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1696608000000, receivedDateStr=2023-10-07, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005984548, onlineDateStr=2026-11-18, pubDate=1717948800000, pubDateStr=2024-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005984548, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005984548, creator=13701087609, updateTime=1795005984548, updator=13701087609, issue=Issue{id=1329914740324807335, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='6', pageStart='743', pageEnd='886', issueExtLink='null', onlineDate='null', pubDate='1717948800000', pubDateStr='2024-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005982713, creator='13701087609', updateTime=1795136155207, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460723852981013, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460723852981014, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=743, endPage=749, ext={EN=ArticleExt(id=1329914748214293251, articleId=1329914748021355266, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Formulation,Process and Quality Control Strategies for Amorphous Solid Dispersion-based Preparations, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

Amorphous solid dispersion is one of the most effective formulation approaches to enhance the oral bioavailability of poorly water-soluble drugs with wide application prospects. However, due to the “aging”, a solid state physical stability problem, which affects the dissolution in vitro and absorption in vivo, the development of amorphous solid dispersion-based preparations faces great challenges. The solid state physical stability is affected by many factors such as formulation composition, preparation process and storage conditions. In this paper, formulation composition, preparation process and quality control of amorphous solid dispersion-based preparations are summarized in order to provide the guidance for the development of amorphous solid dispersion-based preparations.

, authors=Xi YANG, Huiyi LI*, authorsList=Xi YANG, Huiyi LI, authorCompany=null, correspAuthors=Huiyi LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914748763747078, articleId=1329914748021355266, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=无定型固体分散体制剂的处方、工艺与质量控制策略, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

无定型固体分散体是提高难溶性药物口服生物利用度的有效策略之一,应用前景广泛。但由于存在固态物理稳定性,即“老化”的问题,会影响药物的体外溶出和体内吸收,给无定型固体分散体制剂的开发带来了较大挑战。固态物理稳定性易受处方组成、制备工艺和贮存条件等多种因素的影响。文章讨论了无定型固体分散体制剂的处方组成、制备工艺和质量控制,以期为其研究和开发提供参考。

, authors=杨茜, 李慧义*, authorsList=杨茜, 李慧义, authorCompany=null, correspAuthors=李慧义, authorNote=

李慧义,处长,研究员,1997年毕业于中国医学科学院中国协和医科大学药物研究所药物分析专业,获博士学位。现任国家药典委员会生物制品处处长,曾任化学药品标准处处长多年。先后在中国药品生物制品检定所和国家药典委员会工作,从事药品质量控制研究、药品国家标准制修订以及药品通用名称命名工作,先后负责组织编纂4个版次《中华人民共和国药典》(二部和三部),审核3 000多份药品国家标准,完成近2 000个药品通用名称命名,组织编写并出版了《中国药品通用名称》《药品红外光谱集》等著作,起草仿制药质量与疗效一致性评价中关于改盐基、改剂型、改规格品种一致性评价的考虑等重要技术文件。

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

, correspAuthorsNote=
李慧义(1970—),女,博士,研究员,从事药品质量控制研究、药品国家标准制修订以及药品通用名称命名工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=24CssGsuaK0mYKOWblwRLg==, magXml=9OLS7/gHjxqQFD4lJJulaA==, pdfUrl=null, pdf=lqytMScGzU4sEp90Iy+C6g==, pdfFileSize=2183566, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=eMM5k+WVR3b1fo71t3wXVw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914749082514187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914749158011661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749082514187, language=EN, stringName=Xi YANG, firstName=Xi, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chinese Pharmacopoeia Commission, Beijing 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914749220926222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749082514187, language=CN, stringName=杨茜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药典委员会,北京 100061, bio={"content":"

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

"}, bioImg=null, bioContent=

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914748994433799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, xref=null, ext=[AuthorCompanyExt(id=1329914749002822408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chinese Pharmacopoeia Commission, Beijing 100061), AuthorCompanyExt(id=1329914749015405321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药典委员会,北京 100061)])]), Author(id=1329914749279646480, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lihuiyi@chp.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914749350949650, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749279646480, language=EN, stringName=Huiyi LI, firstName=Huiyi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Chinese Pharmacopoeia Commission, Beijing 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914749422252819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749279646480, language=CN, stringName=李慧义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药典委员会,北京 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914748994433799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, xref=null, ext=[AuthorCompanyExt(id=1329914749002822408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chinese Pharmacopoeia Commission, Beijing 100061), AuthorCompanyExt(id=1329914749015405321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药典委员会,北京 100061)])])], keywords=[Keyword(id=1329914749501944596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=EN, orderNo=1, keyword=amorphous solid dispersion), Keyword(id=1329914749573247765, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=EN, orderNo=2, keyword=formulation), Keyword(id=1329914749636162326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=EN, orderNo=3, keyword=preparation process), Keyword(id=1329914749694882583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=EN, orderNo=4, keyword=physical stability), Keyword(id=1329914749766185752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=EN, orderNo=5, keyword=quality control), Keyword(id=1329914749829100313, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=CN, orderNo=1, keyword=无定型固体分散体), Keyword(id=1329914749883626266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=CN, orderNo=2, keyword=处方), Keyword(id=1329914749946540827, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=CN, orderNo=3, keyword=制备工艺), Keyword(id=1329914750013649692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=CN, orderNo=4, keyword=物理稳定性), Keyword(id=1329914750072369949, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, language=CN, orderNo=5, keyword=质量控制)], refs=[Reference(id=1329914750160450334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=TRAN P, PYO Y C, KIM D H, et al.Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs [J].Pharmaceutics, 2019, 11(3): 132., articleTitle=null, refAbstract=null), Reference(id=1329914750227559199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=MAHMOOD T, SARFRAZ R M, ISMAIL A, et al.Pharmaceutical methods for enhancing the dissolution of poorly water-soluble drugs [J].Assay Drug Dev Technol, 2023, 21(2): 65-79., articleTitle=null, refAbstract=null), Reference(id=1329914750303056672, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUNA R, DE MORAIS L A, VIANA M C, et al.Promising strategies for improving oral bioavailability of poor water-soluble drugs [J].Expert Opin Drug Discov, 2023, 18(6): 615-627., articleTitle=null, refAbstract=null), Reference(id=1329914750374359841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JOSHI K, CHANDRA A, JAIN K, et al.Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs [J].Pharm Nanotechnol, 2019, 7(4): 259-278., articleTitle=null, refAbstract=null), Reference(id=1329914750449857314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DI L, FISH P V, MANO T.Bridging solubility between drug discovery and development [J].Drug Discov Today, 2012, 17(9/10): 486-495., articleTitle=null, refAbstract=null), Reference(id=1329914750521160483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=吴昊旻,张杰,蔡挺,等.无定形固体分散体的溶出与吸收研究进展[J].药学学报,2022,57(5):1312-1321., articleTitle=null, refAbstract=null), Reference(id=1329914750588269348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=HATE S S, REUTZEL-EDENS S M, TAYLOR L S.Insight into amorphous solid dispersion performance by coupled dissolution and membrane mass transfer measurements [J].Mol Pharm, 2019, 16(1): 448-461., articleTitle=null, refAbstract=null), Reference(id=1329914750676349733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG X L, ZHANG L, MA D Y, et al.Characterizing and exploring the differences in dissolution and stability between crystalline solid dispersion and amorphous solid dispersion [J].AAPS PharmSciTech, 2020, 21(7): 262-269., articleTitle=null, refAbstract=null), Reference(id=1329914750743458598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=胡洋,杨奕,杨子毅,等.固体分散体制备工艺对其物理稳定性的影响[J].沈阳药科大学学报,2022,39(1):98-104., articleTitle=null, refAbstract=null), Reference(id=1329914750814761767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=BHUJBAL S V, MITRA B, JAIN U, et al.Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies [J].Acta Pharm Sin B, 2021, 11(8): 2505-2536., articleTitle=null, refAbstract=null), Reference(id=1329914750877676328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=AGRAWAL A M, DUDHEDIA M S, PATEL A D, et al.Characterization and performance assessment of solid dispersions prepared by hot melt extrusion and spray drying process [J].Int J Pharm, 2013, 457(1): 71-81., articleTitle=null, refAbstract=null), Reference(id=1329914750944785193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=BAGHEL S, CATHCART H, O'REILLY N J.Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class Ⅱ drugs [J].J Pharm Sci, 2016, 105(9): 2527-2544., articleTitle=null, refAbstract=null), Reference(id=1329914751007699754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI Q, CHEN H B, WANG Y N, et al.Amorphous solid dispersions: role of the polymer and its importance in physical stability and in vitro performance [J].Pharmaceutics, 2022, 14(8): 1747-1771., articleTitle=null, refAbstract=null), Reference(id=1329914751070614315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=MARSAC P J, SHAMBLIN S L, TAYLOR L S.Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility [J].Pharm Res, 2006, 23(10): 2417-2426., articleTitle=null, refAbstract=null), Reference(id=1329914751133528876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=AYENEW Z, PAUDEL A, VAN DEN MOOTER G.Can compression induce demixing in amorphous solid dispersions? A case study of naproxene-PVP K25 [J].Eur J Pharm Biopharm, 2012, 81(1): 207-213., articleTitle=null, refAbstract=null), Reference(id=1329914751200637741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=BUTREDDY A.Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: a review from bench to clinic [J].Eur J Pharm Biopharm, 2022, 177(10): 289-307., articleTitle=null, refAbstract=null), Reference(id=1329914751263552302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAVAN R B, RATHI S, JYOTHI V G S S, et al.Cellulose based polymers in development of amorphous solid dispersions [J].Asian J Pharm Sci, 2019, 14(3): 248-264., articleTitle=null, refAbstract=null), Reference(id=1329914751343244079, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSIAK N, WDOWIAK K, TYKARSKA E, et al.Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases [J].Int J Mol Sci, 2022, 23(23): 15198-15217., articleTitle=null, refAbstract=null), Reference(id=1329914751414547248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIM J B, LEE J K, JO H, et al.Effect of acidifier on the dissolution property of a solid dispersion of raloxifene HCl [J].Macromol Res, 2013, 21(1): 42-48., articleTitle=null, refAbstract=null), Reference(id=1329914751485850417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=RAHAMAN M A, KESHTMAND M.喷雾干燥制备固体分散体中聚合物的筛选和优化以提高生物利用度[EB/OL].[2023-04-16].https://www.ashlandchina.com/uploads/2015/05/071050416350.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914751552959282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=AGRAWAL A, DUDHEDIA M, DENG W, et al.Development of tablet formulation of amorphous solid dispersions prepared by hot melt extrusion using quality by design approach [J].AAPS PharmSciTech, 2016, 17(1): 214-232., articleTitle=null, refAbstract=null), Reference(id=1329914751641039667, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, ZHANG F, MCGINITY J W.Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion [J].Eur J Pharm Biopharm, 2001, 52(2): 181-190., articleTitle=null, refAbstract=null), Reference(id=1329914751716537140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=AGRAWAL A M, DUDHEDIA M S, ZIMNY E.Hot melt extrusion: development of an amorphous solid dispersion for an insoluble drug from mini-scale to clinical scale [J].AAPS PharmSciTech, 2016, 17(1): 133-147., articleTitle=null, refAbstract=null), Reference(id=1329914751804617525, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=SIRIWANNAKIJ N, HEIMBACH T, SERAJUDDIN A T M.Aqueous dissolution and dispersion behavior of polyvinylpyrrolidone vinyl acetate-based amorphous solid dispersion of ritonavir prepared by hot-melt extrusion with and without added surfactants [J].J Pharm Sci, 2021, 110(4): 1480-1494., articleTitle=null, refAbstract=null), Reference(id=1329914751884309302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SOLOMOS M A, PUNIA A, SABOO S, et al.Evaluating spray drying and co-precipitation as manufacturing processes for amorphous solid dispersions of a low Tg API [J].J Pharm Sci, 2023, 112(8): 2087-2096., articleTitle=null, refAbstract=null), Reference(id=1329914751955612471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=NESPI M, KUHN R, YEN C W, et al.Optimization of spray-drying parameters for formulation development at preclinical scale [J].AAPS PharmSciTech, 2021, 23(1): 28-39., articleTitle=null, refAbstract=null), Reference(id=1329914752064664376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=HERMANS A, MILSMANN J, Li H L, et al.Challenges and strategies for solubility measurements and dissolution method development for amorphous solid dispersion formulations [J].AAPS J, 2022, 25(1): 11., articleTitle=null, refAbstract=null), Reference(id=1329914752135967545, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=JELIĆ D.Thermal stability of amorphous solid dispersions [J].Molecules, 2021, 26(1): 238., articleTitle=null, refAbstract=null), Reference(id=1329914752194687802, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=HASER A, ZHANG F.New strategies for improving the development and performance of amorphous solid dispersions[J].AAPS PharmSciTech, 2018, 19(3): 978-990., articleTitle=null, refAbstract=null), Reference(id=1329914752324711227, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=BHUJBAL S V, PATHAK V, ZEMLYANOV D Y, et al.Physical stability and dissolution of lumefantrine amorphous solid dispersions produced by spray anti-solvent precipitation[J].J Pharm Sci, 2021, 110(6): 2423-2431., articleTitle=null, refAbstract=null), Reference(id=1329914752396014396, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J H, WANG Y H, YU D Y.Effects of additives on the physical stability and dissolution of polymeric amorphous solid dispersions: a review [J].AAPS PharmSciTech, 2023, 24(7): 175., articleTitle=null, refAbstract=null), Reference(id=1329914752458928957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAMS H D, TREVASKIS N L, CHARMAN S A, et al.Strategies to address low drug solubility in discovery and development [J].Pharmacol Rev, 2013, 65(1): 315-499., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914748994433799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, xref=null, ext=[AuthorCompanyExt(id=1329914749002822408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chinese Pharmacopoeia Commission, Beijing 100061), AuthorCompanyExt(id=1329914749015405321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药典委员会,北京 100061)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.06.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.06.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.06.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.06.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1717948800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
无定型固体分散体制剂的处方、工艺与质量控制策略
杨茜 , 李慧义 *
中国医药工业杂志 | 专论 2024,55(6): 743-749
收起
收藏切换
中国医药工业杂志 |专论 2024 , 55 (6) : 743 -749
无定型固体分散体制剂的处方、工艺与质量控制策略
全屏
[Author(id=1329914749082514187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914749158011661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749082514187, language=EN, stringName=Xi YANG, firstName=Xi, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Chinese Pharmacopoeia Commission, Beijing 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914749220926222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749082514187, language=CN, stringName=杨茜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药典委员会,北京 100061, bio={"content":"

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

"}, bioImg=null, bioContent=

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914748994433799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, xref=null, ext=[AuthorCompanyExt(id=1329914749002822408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chinese Pharmacopoeia Commission, Beijing 100061), AuthorCompanyExt(id=1329914749015405321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药典委员会,北京 100061)])]), Author(id=1329914749279646480, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lihuiyi@chp.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914749350949650, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749279646480, language=EN, stringName=Huiyi LI, firstName=Huiyi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Chinese Pharmacopoeia Commission, Beijing 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914749422252819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, authorId=1329914749279646480, language=CN, stringName=李慧义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药典委员会,北京 100061, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914748994433799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, xref=null, ext=[AuthorCompanyExt(id=1329914749002822408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Chinese Pharmacopoeia Commission, Beijing 100061), AuthorCompanyExt(id=1329914749015405321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914748021355266, companyId=1329914748994433799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药典委员会,北京 100061)])])]
杨茜, 李慧义*
作者信息
  • 国家药典委员会,北京 100061
通讯作者:
李慧义(1970—),女,博士,研究员,从事药品质量控制研究、药品国家标准制修订以及药品通用名称命名工作。E-mail:
作者简介:

李慧义,处长,研究员,1997年毕业于中国医学科学院中国协和医科大学药物研究所药物分析专业,获博士学位。现任国家药典委员会生物制品处处长,曾任化学药品标准处处长多年。先后在中国药品生物制品检定所和国家药典委员会工作,从事药品质量控制研究、药品国家标准制修订以及药品通用名称命名工作,先后负责组织编纂4个版次《中华人民共和国药典》(二部和三部),审核3 000多份药品国家标准,完成近2 000个药品通用名称命名,组织编写并出版了《中国药品通用名称》《药品红外光谱集》等著作,起草仿制药质量与疗效一致性评价中关于改盐基、改剂型、改规格品种一致性评价的考虑等重要技术文件。

杨茜(1982—),女,博士,助理研究员,从事化学药品处方工艺及质量研究和化学药品国家标准制修订工作。

Formulation,Process and Quality Control Strategies for Amorphous Solid Dispersion-based Preparations
Xi YANG, Huiyi LI*
Affiliations
  • Chinese Pharmacopoeia Commission, Beijing 100061
出版时间: 2024-06-10 doi: 10.16522/j.cnki.cjph.2024.06.001
文章导航
收藏切换

无定型固体分散体是提高难溶性药物口服生物利用度的有效策略之一,应用前景广泛。但由于存在固态物理稳定性,即“老化”的问题,会影响药物的体外溶出和体内吸收,给无定型固体分散体制剂的开发带来了较大挑战。固态物理稳定性易受处方组成、制备工艺和贮存条件等多种因素的影响。文章讨论了无定型固体分散体制剂的处方组成、制备工艺和质量控制,以期为其研究和开发提供参考。

无定型固体分散体  /  处方  /  制备工艺  /  物理稳定性  /  质量控制

Amorphous solid dispersion is one of the most effective formulation approaches to enhance the oral bioavailability of poorly water-soluble drugs with wide application prospects. However, due to the “aging”, a solid state physical stability problem, which affects the dissolution in vitro and absorption in vivo, the development of amorphous solid dispersion-based preparations faces great challenges. The solid state physical stability is affected by many factors such as formulation composition, preparation process and storage conditions. In this paper, formulation composition, preparation process and quality control of amorphous solid dispersion-based preparations are summarized in order to provide the guidance for the development of amorphous solid dispersion-based preparations.

amorphous solid dispersion  /  formulation  /  preparation process  /  physical stability  /  quality control
杨茜, 李慧义. 无定型固体分散体制剂的处方、工艺与质量控制策略. 中国医药工业杂志, 2024 , 55 (6) : 743 -749 . DOI: 10.16522/j.cnki.cjph.2024.06.001
Xi YANG, Huiyi LI. Formulation,Process and Quality Control Strategies for Amorphous Solid Dispersion-based Preparations[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (6) : 743 -749 . DOI: 10.16522/j.cnki.cjph.2024.06.001

参考文献 引证文献
排序方式:
[1]
TRAN P, PYO Y C, KIM D H, et al.Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs [J].Pharmaceutics, 2019, 11(3): 132.
[2]
MAHMOOD T, SARFRAZ R M, ISMAIL A, et al.Pharmaceutical methods for enhancing the dissolution of poorly water-soluble drugs [J].Assay Drug Dev Technol, 2023, 21(2): 65-79.
[3]
BRUNA R, DE MORAIS L A, VIANA M C, et al.Promising strategies for improving oral bioavailability of poor water-soluble drugs [J].Expert Opin Drug Discov, 2023, 18(6): 615-627.
[4]
JOSHI K, CHANDRA A, JAIN K, et al.Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs [J].Pharm Nanotechnol, 2019, 7(4): 259-278.
[5]
DI L, FISH P V, MANO T.Bridging solubility between drug discovery and development [J].Drug Discov Today, 2012, 17(9/10): 486-495.
[6]
吴昊旻,张杰,蔡挺,等.无定形固体分散体的溶出与吸收研究进展[J].药学学报,2022,57(5):1312-1321.
[7]
HATE S S, REUTZEL-EDENS S M, TAYLOR L S.Insight into amorphous solid dispersion performance by coupled dissolution and membrane mass transfer measurements [J].Mol Pharm, 2019, 16(1): 448-461.
[8]
WANG X L, ZHANG L, MA D Y, et al.Characterizing and exploring the differences in dissolution and stability between crystalline solid dispersion and amorphous solid dispersion [J].AAPS PharmSciTech, 2020, 21(7): 262-269.
[9]
胡洋,杨奕,杨子毅,等.固体分散体制备工艺对其物理稳定性的影响[J].沈阳药科大学学报,2022,39(1):98-104.
[10]
BHUJBAL S V, MITRA B, JAIN U, et al.Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies [J].Acta Pharm Sin B, 2021, 11(8): 2505-2536.
[11]
AGRAWAL A M, DUDHEDIA M S, PATEL A D, et al.Characterization and performance assessment of solid dispersions prepared by hot melt extrusion and spray drying process [J].Int J Pharm, 2013, 457(1): 71-81.
[12]
BAGHEL S, CATHCART H, O'REILLY N J.Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class Ⅱ drugs [J].J Pharm Sci, 2016, 105(9): 2527-2544.
[13]
SHI Q, CHEN H B, WANG Y N, et al.Amorphous solid dispersions: role of the polymer and its importance in physical stability and in vitro performance [J].Pharmaceutics, 2022, 14(8): 1747-1771.
[14]
MARSAC P J, SHAMBLIN S L, TAYLOR L S.Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility [J].Pharm Res, 2006, 23(10): 2417-2426.
[15]
AYENEW Z, PAUDEL A, VAN DEN MOOTER G.Can compression induce demixing in amorphous solid dispersions? A case study of naproxene-PVP K25 [J].Eur J Pharm Biopharm, 2012, 81(1): 207-213.
[16]
BUTREDDY A.Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: a review from bench to clinic [J].Eur J Pharm Biopharm, 2022, 177(10): 289-307.
[17]
CHAVAN R B, RATHI S, JYOTHI V G S S, et al.Cellulose based polymers in development of amorphous solid dispersions [J].Asian J Pharm Sci, 2019, 14(3): 248-264.
[18]
ROSIAK N, WDOWIAK K, TYKARSKA E, et al.Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases [J].Int J Mol Sci, 2022, 23(23): 15198-15217.
[19]
SHIM J B, LEE J K, JO H, et al.Effect of acidifier on the dissolution property of a solid dispersion of raloxifene HCl [J].Macromol Res, 2013, 21(1): 42-48.
[20]
RAHAMAN M A, KESHTMAND M.喷雾干燥制备固体分散体中聚合物的筛选和优化以提高生物利用度[EB/OL].[2023-04-16].https://www.ashlandchina.com/uploads/2015/05/071050416350.pdf.
[21]
AGRAWAL A, DUDHEDIA M, DENG W, et al.Development of tablet formulation of amorphous solid dispersions prepared by hot melt extrusion using quality by design approach [J].AAPS PharmSciTech, 2016, 17(1): 214-232.
[22]
LIU J, ZHANG F, MCGINITY J W.Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion [J].Eur J Pharm Biopharm, 2001, 52(2): 181-190.
[23]
AGRAWAL A M, DUDHEDIA M S, ZIMNY E.Hot melt extrusion: development of an amorphous solid dispersion for an insoluble drug from mini-scale to clinical scale [J].AAPS PharmSciTech, 2016, 17(1): 133-147.
[24]
SIRIWANNAKIJ N, HEIMBACH T, SERAJUDDIN A T M.Aqueous dissolution and dispersion behavior of polyvinylpyrrolidone vinyl acetate-based amorphous solid dispersion of ritonavir prepared by hot-melt extrusion with and without added surfactants [J].J Pharm Sci, 2021, 110(4): 1480-1494.
[25]
SOLOMOS M A, PUNIA A, SABOO S, et al.Evaluating spray drying and co-precipitation as manufacturing processes for amorphous solid dispersions of a low Tg API [J].J Pharm Sci, 2023, 112(8): 2087-2096.
[26]
NESPI M, KUHN R, YEN C W, et al.Optimization of spray-drying parameters for formulation development at preclinical scale [J].AAPS PharmSciTech, 2021, 23(1): 28-39.
[27]
HERMANS A, MILSMANN J, Li H L, et al.Challenges and strategies for solubility measurements and dissolution method development for amorphous solid dispersion formulations [J].AAPS J, 2022, 25(1): 11.
[28]
JELIĆ D.Thermal stability of amorphous solid dispersions [J].Molecules, 2021, 26(1): 238.
[29]
HASER A, ZHANG F.New strategies for improving the development and performance of amorphous solid dispersions[J].AAPS PharmSciTech, 2018, 19(3): 978-990.
[30]
BHUJBAL S V, PATHAK V, ZEMLYANOV D Y, et al.Physical stability and dissolution of lumefantrine amorphous solid dispersions produced by spray anti-solvent precipitation[J].J Pharm Sci, 2021, 110(6): 2423-2431.
[31]
LI J H, WANG Y H, YU D Y.Effects of additives on the physical stability and dissolution of polymeric amorphous solid dispersions: a review [J].AAPS PharmSciTech, 2023, 24(7): 175.
[32]
WILLIAMS H D, TREVASKIS N L, CHARMAN S A, et al.Strategies to address low drug solubility in discovery and development [J].Pharmacol Rev, 2013, 65(1): 315-499.
2024年第55卷第6期
27
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.06.001
  • 接收时间:2023-10-07
  • 首发时间:2026-11-18
  • 出版时间:2024-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-10-07
基金
作者信息
    国家药典委员会,北京 100061

通讯作者:

李慧义(1970—),女,博士,研究员,从事药品质量控制研究、药品国家标准制修订以及药品通用名称命名工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.06.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏